CCS is proud to announce its partnership with the GlassWall Syndicate to help drive investment toward the best, most effective medical research testing methods possible. The GlassWall Syndicate is a large group of venture capitalists, foundations, trusts, non-profits, and individual investors who share a similar investment thesis and want to accelerate mainstream adoption of products and services that will make a difference in the lives of animals, people and that are better for the planet.
At CCS, we believe that the best way to improve human health is to cut out the animals (i.e., animal testing). Medical research needs to focus on human biology. Toward that aim, CCS seeks partnerships with investors and funders to accelerate scientific innovation.
Are you an investor and want to partner with CCS to drive medical science innovation? Please email us at email@example.com.
Are you a company on the cutting-edge of medical research, creating human-biology based testing methods? See here about this new investment opportunity.